Victoria Whyte - GlaxoSmithKline plc Insider

GSKN -- Mexico Stock  

MXN 797.90  0.000024  0.00%

Company Secretary

Ms. Victoria L. Whyte serves as Company Secretary of GlaxoSmithKline PLC., since 1 January 2011. She is a solicitor and a Fellow of the Institute of Chartered Secretaries and Administrators. Victoria was formerly Deputy Secretary and Secretary to the Remuneration Committee. She has acted as Secretary to the Board and all the Boards Committees since her appointment as Company Secretary on 1 January 2011.
  Executive Since 2011      
44 20 8047 5000

Management Efficiency

The company has return on total asset (ROA) of 7.37 % which means that it generated profit of $7.37 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 51.32 % meaning that it generated $51.32 on every $100 dollars invested by stockholders.
The company has accumulated 24.07 B in total debt with debt to equity ratio (D/E) of 489.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. GlaxoSmithKline plc has Current Ratio of 0.59 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Similar Executives

Entity Summary

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. GlaxoSmithKline plc is traded on Mexico Stock Exchange in Mexico.GlaxoSmithKline plc (GSKN) is traded on Mexico Stock Exchange in Mexico. It is located in 980 Great West Road and employs 98,462 people.

GlaxoSmithKline plc Leadership Team

Vindi Banga, Director
Lynn Elsenhans, Director
Luke Miels, President, MBA
Hal Barron, President, Ph.D
Daniel Podolsky, Director
Emma Walmsley, President
Luc Debruyne, President
Andrew Witty, CEO, MBA
Brian McNamara, CEO, MBA
Roy Anderson, Director
Philip Hampton, Director
Simon Dingemans, Director
Vivienne Cox, Director, Ph.D
Bill Louv, President
Roger Connor, President
Abbas Hussain, President
Phil Thomson, President
Judy Lewent, Director
Hans Wijers, Director
Stephanie Burns, Director, Ph.D
Moncef Slaoui, Chairman, Ph.D
Urs Rohner, Director
Deryck Maughan, Director
Jesse Goodman, Director, Ph.D
Laurie Glimcher, Director
Nick Hirons, President
Victoria Whyte, Executive
Daniel Troy, SVP
Shah Hussain, President
Manvinder Banga, Director
David Redfern, Executive
Patrick Vallance, President
Stacey Cartwright, Director
Karenann Terrell, Executive
Claire Thomas, President

Stock Performance Indicators

Did you try this?

Run Price Exposure Probability Now

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Price Exposure Probability

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.